SC
PTX

Sageview Capital’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Sageview Capital’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-222,334
Closed -$11.9M – 6
2014
Q1 		$11.9M Hold
222,334
– – 3.76% 3
2013
Q4 		$5.6M Hold
222,334
– – 1.59% 5
2013
Q3 		$6.05M Hold
222,334
– – 1.81% 7
2013
Q2 		$8.03M Buy
+222,334
New +$8.34M 2.18% 6

Other funds holding PTX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Sageview Capital's PTX Position: Q2 2014 in Review

Sageview Capital sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2014, closing a stake of 222,334 shares — an estimated $11.9M sold.

Sageview Capital first reported a position in PTX in Q2 2013 and held it in 4 quarters. The position peaked at $11.9M in Q1 2014. 89 funds tracked by Wall St. Rank hold PTX as of Q2 2014.

  • Sageview Capital reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2014 after selling out during the quarter.
  • Sageview Capital sold 222,334 Pernix Therapeutics Holdings, Inc. shares in Q2 2014, an estimated $11.9M.
  • Sageview Capital first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 4 quarters.
  • Sageview Capital's Pernix Therapeutics Holdings, Inc. position peaked at $11.9M in Q1 2014.
  • 89 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2014.

Based on Sageview Capital's 13F filing for Q2 2014, filed 14 Aug 2014.